DEUTSCHE BANK AG\
BankPosition in AVXL — Anavex Life Sciences Corp.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in AVXL
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$205,469
-$24,458 QoQ
Shares Held
79,332
+5.9% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 179 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. AVXL ranks #238 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in AVXL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $205,469 | 79,332 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $229,927 | 74,895 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $247,586 | 69,547 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $646,798 | 72,674 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $568,836 | 61,696 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $507,755 | 59,179 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $693,202 | 64,544 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $224,472 | 39,520 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $105,470 | 24,993 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $192,274 | 37,775 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $377,622 | 40,561 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $248,107 | 37,879 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $281,777 | 34,659 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $431,293 | 50,326 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $382,428 | 41,299 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $308,123 | 29,857 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,499,467 | 149,797 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $1,900,650 | 154,399 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,734,795 | 157,716 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $2,778,317 | 154,781 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $3,536,830 | 154,717 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $592,228 | 39,614 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $214,093 | 39,647 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $131,244 | 28,845 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $129,750 | 26,372 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $58,076 | 18,437 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||